Biomarkers in Hematology and Oncology

A cancer biomarker indicates to a substance or process that symbolizes the presence of cancer in the body. A biomarker might be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be preferred for cancer diagnosis, prognosis, and epidemiology. A cancer biomarker refers to a substance that indicates the presence of cancer in the body. A biomarker may be a molecule produced by a tumor or a specific response of the body to the presence of cancer. Epigenetic, proteomic, genetic, glycomic and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology.

 A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer, The most vital use of biomarkers today is to diagnose which therapies a patient’s cancer may or may not respond to

 

  • Molecular Cancer Biomarkers
  • Predictive & Prognostic Biomarkers
  • Predictive & Prognostic Biomarkers
  • Companion Biomarker
  • Patient Assessment & Education
  • Forensic Pathology

Related Conference of Biomarkers in Hematology and Oncology

April 30-30, 2024

14th International Conference on Womens Health and Cancer Cure

Amsterdam, Netherlands
July 25-26, 2024

20th World Summit on Blockchain Technology

Amsterdam, Netherlands
August 20-21, 2024

11th World Summit on Epilepsy and Bipolar Disorders

Montreal, Canada
September 26-27, 2024

7th Annual Congress on Emergency Medicine and Acute Care

Amsterdam, Netherlands
October 14-15, 2024

11th World Machine Learning and Deep learning Conference

Barcelona, Spain

Biomarkers in Hematology and Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in